Who is sponsoring NCT04450121?

NCT04450121 is sponsored by Cairo University.

What drugs are being tested in NCT04450121?

Interventions in NCT04450121: Patients will be intubated using Air-Q airway.

What condition does NCT04450121 study?

NCT04450121 studies Fekry VS the Air-Q Intubating Airways.

Is NCT04450121 still recruiting?

NCT04450121 is currently completed. Last updated 30 June 2020.

Last reviewed 2020-06-30 · How we verify

NCT04450121

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison Between Fekry and Air-Q Intubating Airways as Conduit for Fibreoptic Endotracheal Intubation in Adult Patients

Completed NA Last updated 30 June 2020

What this trial tests

NA trial testing Patients will be intubated using Air-Q airway in Fekry VS the Air-Q Intubating Airways in 44 participants. Completed in 3 October 2019.

Timeline

9 January 2019

Primary endpoint
15 September 2019

3 October 2019

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	diagnostic
Enrollment	44
Start date	9 January 2019
Primary completion	15 September 2019
Estimated completion	3 October 2019
Sites	1 location across Egypt

Drugs / interventions tested

Patients will be intubated using Air-Q airway

Conditions studied

Fekry VS the Air-Q Intubating Airways — all drugs for Fekry VS the Air-Q Intubating Airways →

Sponsor

Cairo University

Who can join

Adults 18 to 65, any sex, with Fekry VS the Air-Q Intubating Airways. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The fibreoptic bronchoscope remains one of the most important methods of intubating patients particularly when there is difficulty with intubation. Facilitating fiberoptic oropharyngeal intubation procedure, specific airways have been devised to push the tongue anteriorly to clear a passage for the fibrescope into the trachea. Of these airways the Air-Q Intubating Laryngeal Airway (Air-Q) (Cookgas, St. Louis, MO, USA) and Fekry Oral Intubating Airway (Ameco Technology, Cairo, Egypt).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04450121 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 30 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04450121.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing